NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely…
Month: February 2025
Grocery Outlet Holding Corp. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – GO
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ: GO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Grocery Outlet…
Class Action Filed Against TELUS International (Cda) Inc. (TIXT) Seeking Recovery for Investors – Contact Levi & Korsinsky
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in TELUS International (Cda) Inc. (“TELUS International” or the “Company”) (NYSE: TIXT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TELUS…
Walgreens Boots Alliance, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights – WBA
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who…
Shareholders that lost money on Arconic Corporation(ARNC) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Arconic Corporation (“Arconic Corporation” or the “Company”) (NYSE: ARNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Arconic Corporation…
GSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights – GSK
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged…
Shareholders of Neumora Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights – NMRA
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Neumora Therapeutics, Inc. (“Neumora Therapeutics, Inc.” or the “Company”) (NASDAQ: NMRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neumora…
ICON Public Limited Company Class Action: Levi & Korsinsky Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 – ICLR
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company (“ICON ” or the “Company”) (NASDAQ: ICLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ICON investors who were…
Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 – REGN
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors…
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIX
NEW YORK, Feb. 28, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. (“ESSA Pharma Inc.” or the “Company”) (NASDAQ: EPIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who…
